Health Care & Life Sciences » Biotechnology | PDL BioPharma Inc.

PDL BioPharma Inc.

PDL BioPharma Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
145.4 M
Public Float
148.12 M
PDL BioPharma Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.42
Market Cap
$372.11 M
Shares Outstanding
119.65 M
Public Float
143.25 M

Profile

Address
932 Southwood Boulevard
Incline Village Nevada 89451
United States
Employees -
Website http://www.pdl.com
Updated 07/08/2019
PDL BioPharma, Inc. produces and markets biopharmaceutical products. It operates through the following segments: Income Generating Assets, Pharmaceutical, and Medical Devices. The Income Generating Assets segment consists of revenues derived from notes and other long-term receivables, royalty rights-at fair value, equity investments, and royalties from issued patents in the United States and elsewhere.

Financials

View All

John Peter McLaughlin
Chief Executive Officer & Director
Elizabeth G. O'Farrell
Director